Concepts (124)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Histocompatibility, Maternal-Fetal | 2 | 2018 | 11 | 0.810 |
Why?
|
Transplantation Tolerance | 3 | 2022 | 617 | 0.680 |
Why?
|
T-Lymphocytes, Regulatory | 4 | 2022 | 2986 | 0.590 |
Why?
|
Leukocytes, Mononuclear | 2 | 2022 | 1835 | 0.530 |
Why?
|
Receptors, Virus | 1 | 2015 | 648 | 0.400 |
Why?
|
Uterus | 1 | 2015 | 710 | 0.380 |
Why?
|
Immune Tolerance | 4 | 2018 | 2257 | 0.370 |
Why?
|
Th17 Cells | 1 | 2015 | 765 | 0.320 |
Why?
|
Fetus | 1 | 2015 | 1879 | 0.290 |
Why?
|
Platelet-Derived Growth Factor | 2 | 2016 | 625 | 0.240 |
Why?
|
Isoantigens | 1 | 2022 | 567 | 0.170 |
Why?
|
Glucuronidase | 1 | 2021 | 207 | 0.170 |
Why?
|
Killer Cells, Natural | 2 | 2018 | 2133 | 0.160 |
Why?
|
Adenosine Triphosphate | 2 | 2022 | 2024 | 0.150 |
Why?
|
Maternal-Fetal Exchange | 1 | 2018 | 455 | 0.140 |
Why?
|
Models, Immunological | 1 | 2018 | 527 | 0.140 |
Why?
|
Heart Transplantation | 2 | 2019 | 3119 | 0.130 |
Why?
|
Alternative Splicing | 1 | 2021 | 1118 | 0.130 |
Why?
|
Toll-Like Receptor 8 | 1 | 2015 | 90 | 0.130 |
Why?
|
Mice, Inbred CBA | 1 | 2015 | 447 | 0.120 |
Why?
|
Interleukin-15 | 1 | 2015 | 184 | 0.120 |
Why?
|
Toll-Like Receptor 7 | 1 | 2015 | 172 | 0.120 |
Why?
|
Antigens, Ly | 1 | 2015 | 291 | 0.120 |
Why?
|
Facial Transplantation | 1 | 2016 | 226 | 0.110 |
Why?
|
Toll-Like Receptors | 1 | 2016 | 592 | 0.110 |
Why?
|
Antibodies | 1 | 2021 | 2459 | 0.110 |
Why?
|
Glycolysis | 1 | 2016 | 825 | 0.110 |
Why?
|
Vascular Endothelial Growth Factor A | 3 | 2019 | 3502 | 0.100 |
Why?
|
Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2015 | 902 | 0.100 |
Why?
|
Chimerism | 1 | 2012 | 158 | 0.100 |
Why?
|
Genes, MHC Class II | 1 | 2012 | 458 | 0.100 |
Why?
|
Proto-Oncogene Proteins c-akt | 2 | 2016 | 2502 | 0.100 |
Why?
|
Th1 Cells | 1 | 2016 | 1056 | 0.100 |
Why?
|
Vascular Diseases | 1 | 2019 | 1155 | 0.090 |
Why?
|
Chemokines | 1 | 2015 | 954 | 0.090 |
Why?
|
TOR Serine-Threonine Kinases | 2 | 2016 | 2107 | 0.090 |
Why?
|
Immunophenotyping | 1 | 2015 | 1866 | 0.090 |
Why?
|
Phosphatidylinositol 3-Kinases | 2 | 2016 | 2938 | 0.090 |
Why?
|
Interleukin-17 | 1 | 2016 | 900 | 0.090 |
Why?
|
Immunologic Factors | 1 | 2019 | 1575 | 0.090 |
Why?
|
Imidazoles | 1 | 2015 | 1205 | 0.080 |
Why?
|
Pancreatic Neoplasms | 2 | 2016 | 5249 | 0.080 |
Why?
|
Cell Proliferation | 4 | 2016 | 10472 | 0.080 |
Why?
|
Dendritic Cells | 1 | 2018 | 2723 | 0.080 |
Why?
|
Interferon-gamma | 1 | 2016 | 3199 | 0.080 |
Why?
|
Placenta | 1 | 2015 | 1694 | 0.070 |
Why?
|
Graft Survival | 1 | 2016 | 3733 | 0.070 |
Why?
|
Pregnancy | 2 | 2018 | 29087 | 0.060 |
Why?
|
Bone Marrow Cells | 1 | 2012 | 2513 | 0.060 |
Why?
|
Macrophages | 1 | 2018 | 5655 | 0.060 |
Why?
|
Animals | 6 | 2022 | 168561 | 0.060 |
Why?
|
Kidney Transplantation | 1 | 2018 | 4246 | 0.060 |
Why?
|
Graft Rejection | 1 | 2016 | 4393 | 0.050 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 2 | 2021 | 3862 | 0.050 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2015 | 5163 | 0.050 |
Why?
|
Cells, Cultured | 2 | 2015 | 19223 | 0.050 |
Why?
|
MAP Kinase Signaling System | 2 | 2016 | 1525 | 0.040 |
Why?
|
Diabetes Mellitus, Type 1 | 1 | 2014 | 3336 | 0.040 |
Why?
|
Signal Transduction | 3 | 2016 | 23387 | 0.040 |
Why?
|
Vascular Endothelial Growth Factor C | 1 | 2019 | 126 | 0.040 |
Why?
|
Vimentin | 1 | 2019 | 261 | 0.040 |
Why?
|
Humans | 13 | 2022 | 742088 | 0.040 |
Why?
|
Metalloendopeptidases | 1 | 1999 | 396 | 0.040 |
Why?
|
Myosins | 1 | 2019 | 409 | 0.040 |
Why?
|
Mice, Inbred C57BL | 1 | 2015 | 21821 | 0.040 |
Why?
|
Postoperative Complications | 1 | 2019 | 15244 | 0.040 |
Why?
|
HT29 Cells | 1 | 2016 | 200 | 0.040 |
Why?
|
Lipoproteins, LDL | 1 | 1999 | 628 | 0.030 |
Why?
|
HCT116 Cells | 1 | 2016 | 408 | 0.030 |
Why?
|
Toll-Like Receptor 9 | 1 | 2016 | 212 | 0.030 |
Why?
|
Cell Line, Tumor | 3 | 2016 | 16665 | 0.030 |
Why?
|
Interleukin-1 | 1 | 1999 | 1262 | 0.030 |
Why?
|
Female | 7 | 2019 | 379592 | 0.030 |
Why?
|
bcl-X Protein | 1 | 2016 | 411 | 0.030 |
Why?
|
Heart Failure | 1 | 2019 | 10856 | 0.030 |
Why?
|
Toll-Like Receptor 2 | 1 | 2016 | 354 | 0.030 |
Why?
|
Kidney Function Tests | 1 | 2016 | 683 | 0.030 |
Why?
|
Pancreatitis, Chronic | 1 | 2016 | 285 | 0.030 |
Why?
|
Toll-Like Receptor 4 | 1 | 2016 | 561 | 0.030 |
Why?
|
Immune System | 1 | 2019 | 804 | 0.030 |
Why?
|
HLA Antigens | 1 | 2019 | 1382 | 0.030 |
Why?
|
Fluorescent Antibody Technique | 1 | 2016 | 2505 | 0.030 |
Why?
|
Adoptive Transfer | 1 | 2014 | 844 | 0.020 |
Why?
|
Neoplasm Transplantation | 1 | 2015 | 2085 | 0.020 |
Why?
|
Apoptosis | 2 | 2016 | 9715 | 0.020 |
Why?
|
Retroviridae | 1 | 2012 | 914 | 0.020 |
Why?
|
Mice, Inbred NOD | 1 | 2014 | 1875 | 0.020 |
Why?
|
Blotting, Western | 1 | 2016 | 5180 | 0.020 |
Why?
|
Neovascularization, Pathologic | 1 | 2019 | 2633 | 0.020 |
Why?
|
Glomerular Filtration Rate | 1 | 2016 | 2167 | 0.020 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 1999 | 4414 | 0.020 |
Why?
|
Skin Transplantation | 1 | 2012 | 1074 | 0.020 |
Why?
|
Endothelium, Vascular | 1 | 1999 | 4455 | 0.020 |
Why?
|
Male | 4 | 2019 | 349538 | 0.020 |
Why?
|
Risk | 1 | 2019 | 9679 | 0.020 |
Why?
|
Follow-Up Studies | 2 | 2019 | 39004 | 0.020 |
Why?
|
Double-Blind Method | 1 | 2019 | 12017 | 0.020 |
Why?
|
Immunosuppressive Agents | 1 | 2018 | 4147 | 0.020 |
Why?
|
Prospective Studies | 2 | 2019 | 53187 | 0.020 |
Why?
|
Proportional Hazards Models | 1 | 2019 | 12344 | 0.010 |
Why?
|
Transplantation, Homologous | 1 | 2012 | 4771 | 0.010 |
Why?
|
Middle Aged | 4 | 2019 | 213127 | 0.010 |
Why?
|
Mice | 3 | 2015 | 81045 | 0.010 |
Why?
|
Gene Expression Profiling | 1 | 2019 | 9410 | 0.010 |
Why?
|
T-Lymphocytes | 1 | 2019 | 10163 | 0.010 |
Why?
|
Matrix Metalloproteinases, Membrane-Associated | 1 | 1999 | 18 | 0.010 |
Why?
|
Adult | 3 | 2019 | 213712 | 0.010 |
Why?
|
Gelatinases | 1 | 1999 | 94 | 0.010 |
Why?
|
Retrospective Studies | 2 | 2019 | 77098 | 0.010 |
Why?
|
Immunotherapy | 1 | 2014 | 4414 | 0.010 |
Why?
|
Matrix Metalloproteinase 2 | 1 | 1999 | 472 | 0.010 |
Why?
|
Colorectal Neoplasms | 1 | 2016 | 6754 | 0.010 |
Why?
|
Prognosis | 1 | 2016 | 29010 | 0.010 |
Why?
|
DNA Primers | 1 | 1999 | 2892 | 0.010 |
Why?
|
Young Adult | 1 | 2019 | 56350 | 0.010 |
Why?
|
Enzyme Activation | 1 | 1999 | 3701 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2019 | 62966 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 1 | 2014 | 17400 | 0.010 |
Why?
|
Risk Factors | 1 | 2016 | 72145 | 0.010 |
Why?
|
Base Sequence | 1 | 1999 | 12797 | 0.000 |
Why?
|
Transcription, Genetic | 1 | 1999 | 7721 | 0.000 |
Why?
|
RNA, Messenger | 1 | 1999 | 13029 | 0.000 |
Why?
|
Aged | 1 | 2015 | 162944 | 0.000 |
Why?
|
Gene Expression Regulation | 1 | 1999 | 12071 | 0.000 |
Why?
|
Concepts
(124)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(20)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_